Literature DB >> 2419758

Expression of apamin receptor in muscles of patients with myotonic muscular dystrophy.

J F Renaud, C Desnuelle, H Schmid-Antomarchi, M Hugues, G Serratrice, M Lazdunski.   

Abstract

Myotonic muscular dystrophy, or Steinert disease, is a dominantly inherited disease of muscle which occurs with a frequency of between 1 in 18,000 and 1 in 7,500 people (refs 1, 2). One of the prominent clinical manifestations is muscle stiffness and difficulty in relaxation of muscles after voluntary contractions. Electrophysiological signs of myotonia include increased excitability with a tendency to fire trains of repetitive action potentials in response to direct electrical and mechanical stimulation. Most experimental and clinical data suggest that myotonic muscular dystrophy arises from genetically induced alterations of the muscle membrane. We show here for the first time that muscle membranes of patients with myotonic muscular dystrophy contain the receptor for apamin, a bee venom toxin known to be a specific and high-affinity blocker of one class of Ca2+-activated K+ channels in mammalian muscle. The apamin receptor is completely absent in normal human muscle as well as in muscles of patients with spinal anterior horn disorders.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419758     DOI: 10.1038/319678a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  19 in total

Review 1.  Ion channels and ion transporters of the transverse tubular system of skeletal muscle.

Authors:  Karin Jurkat-Rott; Michael Fauler; Frank Lehmann-Horn
Journal:  J Muscle Res Cell Motil       Date:  2006-08-24       Impact factor: 2.698

2.  Expression of small-conductance calcium-activated potassium channels (SK3) in skeletal muscle: regulation by muscle activity.

Authors:  Morgana Favero; De-Jian Jiang; Christian Chiamulera; Alberto Cangiano; Guido Francesco Fumagalli
Journal:  J Physiol       Date:  2008-08-14       Impact factor: 5.182

Review 3.  Calcium-activated potassium channels: regulation by calcium.

Authors:  O B McManus
Journal:  J Bioenerg Biomembr       Date:  1991-08       Impact factor: 2.945

4.  Voltage-dependent K+ channels in the sarcolemma of mouse skeletal muscle.

Authors:  H Brinkmeier; E Zachar; R Rüdel
Journal:  Pflugers Arch       Date:  1991-11       Impact factor: 3.657

5.  Identification of a novel protein, DMAP, which interacts with the myotonic dystrophy protein kinase and shows strong homology to D1 snRNP.

Authors:  Y H Fu
Journal:  Genetica       Date:  1996-01       Impact factor: 1.082

Review 6.  Ionic transporting systems of skeletal muscle in relation with innervation and their involvement in myotonic diseases.

Authors:  J F Renaud
Journal:  Neurochem Res       Date:  1991-06       Impact factor: 3.996

7.  Myotonic dystrophy protein kinase is involved in the modulation of the Ca2+ homeostasis in skeletal muscle cells.

Authors:  A A Benders; P J Groenen; F T Oerlemans; J H Veerkamp; B Wieringa
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

8.  Deficiency of Na+/K(+)-ATPase and sarcoplasmic reticulum Ca(2+)-ATPase in skeletal muscle and cultured muscle cells of myotonic dystrophy patients.

Authors:  A A Benders; J A Timmermans; A Oosterhof; H J Ter Laak; T H van Kuppevelt; R A Wevers; J H Veerkamp
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

9.  Properties of receptors for neurotoxic phospholipases A2 in different tissues.

Authors:  G Lambeau; M Lazdunski; J Barhanin
Journal:  Neurochem Res       Date:  1991-06       Impact factor: 3.996

Review 10.  Myotonic Dystrophy Type 1 Management and Therapeutics.

Authors:  Cheryl A Smith; Laurie Gutmann
Journal:  Curr Treat Options Neurol       Date:  2016-12       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.